Search results
Results from the WOW.Com Content Network
A new study found that people who have had COVID-19 are more likely to develop chronic fatigue syndrome. A researcher and doctor weigh in on the symptoms to watch for.
However, loss of olfaction is not unique to COVID-19; approximately 13% of patients with influenza also lose olfaction, as do patients with MERS-CoV and Ebola virus. [11] Among the patients with COVID-19, 50% of patients recover olfaction within 14 days, and 89% of patients have complete resolution of their loss of olfaction within 4 weeks.
Long COVID symptoms, such as brain fog, could be caused by a reduction in serotonin levels, new study finds. Experts explain.
ongoing symptomatic COVID-19 for effects from four to twelve weeks after onset, and; post-COVID-19 syndrome for effects that persist 12 or more weeks after onset. The clinical case definitions specify symptom onset and development. For instance, the WHO definition indicates that "symptoms might be new onset following initial recovery or persist ...
The unknown effects of SARS-CoV-2 on the developing fetus, limited treatment options, and reduced available resources leave many women facing the difficult decision of whether to try to conceive or delay pregnancy. For example, in one study, 37.3% of survey participants who wanted children before the COVID-19 pandemic no longer wanted children ...
Is COVID rebound a reason not to take Paxlovid? “If someone qualifies for Paxlovid, it is still in their best interest to take Paxlovid, even if there may be an increased risk of rebound ...
Longer-term effects of COVID-19 have become a prevalent aspect of the disease itself. These symptoms can be referred to by many names including post-COVID-19 syndrome, long COVID, and long haulers syndrome. An overall definition of post-COVID conditions (PCC) can be described as a range of symptoms that can last for weeks or months. [83]
The reason COVID-19 cases increased this summer is likely because people who hadn’t been recently vaccinated or infected had fewer antibodies at the ready to fight off the first sign of the ...